Suivre
Mohammad(Shahriar) Absar
Mohammad(Shahriar) Absar
Adresse e-mail validée de fda.hhs.gov
Titre
Citée par
Citée par
Année
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals
K Nahar, N Gupta, R Gauvin, S Absar, B Patel, V Gupta, ...
European journal of pharmaceutical sciences 49 (5), 805-818, 2013
1592013
Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature
K Nahar, S Absar, B Patel, F Ahsan
International journal of pharmaceutics 464 (1-2), 185-195, 2014
792014
Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy
S Absar, K Nahar, YM Kwon, F Ahsan
Pharmaceutical research 30, 1663-1676, 2013
762013
Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis
S Absar, YM Kwon, F Ahsan
Journal of controlled release 177, 42-50, 2014
512014
Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers
S Bhagwat, U Schilling, MJ Chen, X Wei, R Delvadia, M Absar, B Saluja, ...
Pharmaceutical research 34, 2541-2556, 2017
502017
Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D
G Kibria, MA Roni, MS Absar, R Jalil
Aaps Pharmscitech 9, 1240-1246, 2008
492008
Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension
K Nahar, S Absar, N Gupta, VR Kotamraju, IF McMurtry, M Oka, ...
Molecular pharmaceutics 11 (12), 4374-4384, 2014
482014
Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy
Y Wu, P Petrochenko, L Chen, SY Wong, M Absar, S Choi, J Zheng
International Journal of Pharmaceutics 505 (1-2), 167-174, 2016
422016
Biopharmaceutics of topical ophthalmic suspensions: Importance of viscosity and particle size in ocular absorption of indomethacin
E Toropainen, SJ Fraser-Miller, D Novakovic, EM Del Amo, KS Vellonen, ...
Pharmaceutics 13 (4), 452, 2021
402021
Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy
S Absar, N Gupta, K Nahar, F Ahsan
Journal of Thrombosis and Haemostasis 13 (9), 1545-1556, 2015
372015
Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis
S Absar, S Choi, VC Yang, YM Kwon
Journal of controlled release 157 (1), 46-54, 2012
372012
Liposomal aerosols of nitric oxide (NO) donor as a long-acting substitute for the ultra-short-acting inhaled NO in the treatment of PAH
K Nahar, J Rashid, S Absar, FI Al-Saikhan, F Ahsan
Pharmaceutical research 33, 1696-1710, 2016
312016
Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products
R Price, J Shur, W Ganley, G Farias, N Fotaki, DS Conti, R Delvadia, ...
The AAPS journal 22, 1-9, 2020
302020
Impact of vehicle physicochemical properties on modeling-based predictions of cyclosporine ophthalmic emulsion bioavailability and tear film breakup time
RL Walenga, AH Babiskin, X Zhang, M Absar, L Zhao, RA Lionberger
Journal of pharmaceutical sciences 108 (1), 620-629, 2019
252019
Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis
S Absar, S Choi, F Ahsan, E Cobos, VC Yang, YM Kwon
Thrombosis Research 131 (3), e91-e99, 2013
242013
Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: a cyclosporine ophthalmic emulsion case
H Qu, J Wang, Y Wu, J Zheng, YSR Krishnaiah, M Absar, S Choi, ...
International journal of pharmaceutics 538 (1-2), 215-222, 2018
222018
Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models
B Patel, R Gauvin, S Absar, V Gupta, N Gupta, K Nahar, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 303 (9 …, 2012
222012
Newer devices and improved formulations of inhaled insulin
J Rashid, S Absar, K Nahar, N Gupta, F Ahsan
Expert Opinion on Drug Delivery 12 (6), 917-928, 2015
202015
Equivalence testing of complex particle size distribution profiles based on earth mover’s distance
M Hu, X Jiang, M Absar, S Choi, D Kozak, M Shen, YT Weng, L Zhao, ...
The AAPS Journal 20, 1-10, 2018
192018
Scientific considerations for the review and approval of first generic mometasone furoate nasal suspension spray in the United States from the bioequivalence perspective
Q Liu, M Absar, B Saluja, C Guo, B Chowdhury, R Lionberger, DP Conner, ...
The AAPS journal 21, 1-6, 2019
142019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20